| Vol. 10.46 – 22 November, 2022 |
| |
|
|
| Signs and symptoms of graft-versus-host disease (GVHD) following solid organ transplantation were nonspecific and include a rash, nausea, appetite loss, diarrhea, and cytopenias. Pancytopenia from marrow-directed GVHD was the primary driver of mortality. [Blood] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers tested whether an MYC-driven polyamine signature, as a liquid biopsy, was predictive of response to anti-CD19 CAR-T therapy in patients with relapsed or refractory large B cell lymphoma. [Cell Reports Medicine] |
|
|
|
| Scientists investigated the mechanisms behind the autoimmune benefits and tested the hypothesis that a microbe synergy could be due to an impact on the host T cell receptor and T cell receptor signal strength. [Science Advances] |
|
|
|
| Investigators reported multi-omic, -threshold and continuous-variable dissection of 9p21 and 9p24 loci and tumor microenvironment of four human papillomavirus–negative head and neck squamous cancer cohorts. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Researchers identified a differential time-dependent reliance of activating T cells on the synthesis versus uptake of various non-essential amino acids, which they corroborated with functional assays. [Cell Reports] |
|
|
|
| To delineate the factors that direct DDR signaling in B cells, scientists expressed a tetracycline-inducible Cas9 nuclease in Rag1-deficient pre-B cells. [EMBO Reports] |
|
|
|
| The authors performed a comprehensive analysis by integrating single-cell transcriptomic data of 40,333 peripheral blood mononuclear cells (PBMCs) and 41,580 skin cells, as well as single-cell chromatin accessibility data of 11,058 PBMCs from an Sézary syndrome patient and matched healthy controls. [Cell Death & Disease] |
|
|
|
| For identification of molecular events driving the pathogenesis of T cell large granular lymphocytic leukemia (T-LGLL), researchers compared the differentially methylated loci between the T-LGLL cases and normal T cells with chromatin segmentation data of benign T cells. [Clinical Epigenetics] |
|
|
|
| Scientists tracked the temporal variations in natural killer—triple-negative breast cancer cell distances and compareed them with terminal cellular transcriptome profiles. [Communications Biology] |
| |
|
|
|
| Investigators discuss the contextual complexity of transforming growth factor-β (TGFβ) signaling in tumor-elicited immune responses and explain how understanding this may guide the development of mechanism-based cancer immunotherapy [Nature Reviews Immunology] |
|
|
|
| The authors propose that the ontogeny of a macrophage constitutes a critical piece of information about its contribution to homeostasis or the progression of disease. [Cell] |
|
|
|
|
| Genmab A/S announced that the FDA has accepted for Priority Review the Biologics License Application for subcutaneous epcoritamab, an investigational bispecific antibody, for the treatment of patients with relapsed/refractory large B cell lymphoma after two or more lines of systemic therapy. [Genmab A/S] |
|
|
|
| VacV Biotherapeutics, a cancer immunotherapy company and Queen Mary spin-out developing innovative viral-based therapies, has advanced its promising pipeline of pre-clinical treatments after strong testing results thus far. [Queen Mary University of London] |
|
|
|
|
| January 22 – 25, 2023 Santa Fe, New Mexico, United States |
|
|
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| Institut Curie – Paris, France |
|
|
|
| STEMCELL Technologies, Inc. – Boston, Massachusetts, United States |
|
|
|
| University of Toronto Mississauga – Mississauga, Ontario, Canada |
|
|
|
| Lund University – Lund, Sweden |
|
|
|
|